1. Product Overview

Cerisflora™酸樱桃浓缩粉 is a premium branded ingredient developed by World-Way Biotech, strategically positioned in the rapidly expanding uric acid management and joint health market. Derived exclusively from the world-renowned Montmorency variety of sour cherry (Prunus cerasus), this 50:1 concentrate powder is standardized to Polyphenols ≥10% and Flavonoids at 2–4%, delivering a potent matrix of anthocyanins, flavonols, phenolic acids, proanthocyanidins, and naturally occurring melatonin.

Native to Western Asia and the Black Sea coastal regions, sour cherry is now cultivated across nearly 40 countries in temperate zones. While long appreciated as a nutritious fruit, its value in uric acid metabolism and gout management has only recently received the rigorous scientific attention it deserves. Cerisflora™ undergoes HPTLC (High-Performance Thin-Layer Chromatography) authentication for every batch, guaranteeing true-to-species Montmorency identity with zero adulteration.

2. Botanical & Source Profile

• Botanical Name: Prunus cerasus L. (sour cherry), Family Rosaceae

• Cultivar: Montmorency — the gold standard sour cherry variety, prized for its exceptionally high polyphenol and anthocyanin content

• Plant Part Used: Whole fruit

• Geographic Origin: Indigenous to Western Asia and the Black Sea region; major production zones now include Michigan (USA), Eastern Europe, and Turkey

• Identity Verification: HPTLC fingerprint analysis demonstrating spot-for-spot correspondence with authentic Prunus cerasus reference standards

• Market Positioning: World-Way Biotech core branded ingredient targeting "Uric Acid Metabolism | Joint Comfort"; currently supplied exclusively through cross-border e-commerce channels

3. Active Ingredients & Standardization

Cerisflora™ delivers a precisely characterized, full-spectrum phytochemical matrix:

• Polyphenols: ≥10% — the primary standardization marker ensuring batch-to-batch consistency

• Flavonoids: 2–4% — encompassing flavonols, flavanols, and anthocyanins

• Anthocyanins: Cyanidin-3-glucosylrutinoside and related compounds — the principal contributors to anti-inflammatory and antioxidant activities

• Flavonols: Quercetin and its glycosides — potent xanthine oxidase (XO) inhibitors

• Phenolic Acids: p-Coumaric acid, chlorogenic acid — supporting antioxidant and anti-inflammatory functions

• Proanthocyanidin B2: A powerful natural antioxidant with vascular health benefits

• Naturally Occurring Melatonin: Supports circadian rhythm regulation and sleep quality

• Ascorbic Acid (Vitamin C): Synergistically enhances the overall antioxidant defense system

4. Health Benefits — The Triple-Action Mechanism

4.1 Pathway 1: Dual-Pathway Uric Acid Management (Inhibition + Excretion)

Cerisflora™ employs a two-pronged strategy to effectively lower serum uric acid levels:

• Inhibition of Uric Acid Production: Key anthocyanins and flavonoids potently inhibit xanthine oxidase (XO) activity, reducing uric acid synthesis at the metabolic source

• Promotion of Uric Acid Excretion: Reduces renal tubular reabsorption of uric acid, facilitating its elimination via urine

• In Vivo Validation: Significantly reduced serum uric acid levels in hyperuricemic mouse models, restoring values to the normal range

4.2 Pathway 2: Multi-Target Anti-Inflammatory & Analgesic Action

• IL-1β Suppression: In vitro studies demonstrate up to 60% inhibition of interleukin-1β secretion — the key pro-inflammatory cytokine that drives acute gout flare-ups by recruiting neutrophils into affected joints

• Dual COX Enzyme Inhibition: Sour cherry blocks both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Notably, its COX-2 inhibitory potency substantially exceeds that of sweet cherry, explaining why sour cherry demonstrates superior anti-inflammatory and analgesic performance

4.3 Pathway 3: Renal Protection & Exercise Recovery

• Renal Protection: Anthocyanins scavenge superoxide radicals generated during XO-catalyzed reactions, mitigating oxidative damage to renal tubules and glomeruli — providing organ-protective benefits alongside uric acid management

• Exercise Recovery: Clinical studies have shown that sour cherry supplementation significantly reduces post-exercise muscle soreness and accelerates recovery following high-intensity training

• Sleep Enhancement: The naturally occurring melatonin content extends benefits to individuals experiencing stress-related insomnia or poor sleep quality

5. Proprietary Manufacturing Process & Quality Systems

World-Way Biotech deploys four core technological innovations to preserve the full spectrum of bioactive compounds:

• Low-Temperature Extraction: The entire extraction process is conducted under cold conditions to maximize retention of thermolabile actives including anthocyanins and melatonin

• Innovative 50:1 Concentration: One kilogram of fresh Montmorency cherries is concentrated to just 50 grams of extract, yielding an extraordinarily high bioactive density

• Proprietary Refinement Step: A dedicated refinement stage between filtration and concentration removes non-active impurities (pectins, cellulose), enhancing both purity and solubility

• UHT Flash Sterilization: Ultra-high-temperature instantaneous sterilization eliminates microorganisms while preserving the natural flavor profile and bioactive integrity

• Complete Workflow: Extraction → Filtration → Refinement → Concentration → UHT Sterilization → Drying → Milling → 3D Blending

Quality Assurance: Pesticide residue screening covers 300+ analytes; heavy metal testing is verified by accredited international third-party laboratories and meets United States standards. The manufacturing facility and product hold HALAL, KOSHER, FSSC 22000, and ISO 9001 certifications. The finished powder presents as a light-red to purplish-red solid with excellent water solubility and no visual impurities.

6. Applications & Dosage Forms

Cerisflora™’s favorable water solubility and sensory characteristics support diverse finished product formats:

• Tablets / Pressed Candies: Standardized polyphenol content enables precise daily dosing

• Hard Capsules: Traditional format with high consumer acceptance

• Powdered Drink Mixes: Perfect for on-the-go single-serve sachets aligned with convenience-driven consumer trends

• Functional Gummies: The rapidly growing "snackified supplement" format, particularly popular among younger demographics

• RTD Beverages / Liquid Shots: Ready-to-drink formats for fast-paced modern lifestyles

• Recommended Daily Dose: 1,000 mg/day

7. Target Audience

Cerisflora™ is precisely positioned for four core consumer segments:

• Uric Acid Managers: Individuals with hyperuricemia or gout in remission seeking a natural adjunct to uric acid management

• Social Diners & High-Purine Consumers: Business professionals with frequent dining engagements and diets rich in red meat, seafood, and alcohol

• Fitness Enthusiasts & Athletes: Regular exercisers seeking accelerated post-workout recovery and reduced muscle soreness

• Stress-Induced Insomniacs: Individuals experiencing poor sleep quality due to stress, benefiting from the naturally occurring melatonin content

8. Market Outlook & Competitive Landscape

The global hyperuricemia and gout management market is on a robust growth trajectory, projected to expand from USD 8.2 billion in 2025 to USD 12.5 billion by 2030, representing a CAGR exceeding 6%. Hyperuricemia now affects 13–25% of the global adult population, with prevalence rates rising in both developed and developing nations driven by urbanization, purine-rich dietary patterns, and increasing obesity rates. Critically, the condition is presenting at progressively younger ages — a demographic trend that substantially expands the addressable market for natural uric acid management solutions.

Cerisflora™’s competitive differentiation rests on three pillars: (1) industry-leading polyphenol standardization (≥10%) that exceeds typical market offerings; (2) a comprehensive triple-action mechanism — inhibiting uric acid production, promoting excretion, and reducing inflammatory pain — that addresses the full uric acid pathology rather than a single target; and (3) dual quality assurance through HPTLC botanical authentication and 300+ pesticide residue screening, providing brands with traceable, verifiable quality commitments. Currently positioned for cross-border e-commerce supply, Cerisflora™ is a premium branded ingredient purpose-built for the global nutraceutical market.

9. Conclusion

Cerisflora™酸樱桃浓缩粉 represents a convergence of the world’s premier sour cherry variety (Montmorency), a rigorously validated triple-action uric acid management mechanism, and pharmaceutical-grade manufacturing with 50:1 concentration and HPTLC authentication. Against the backdrop of a global hyperuricemia epidemic affecting one in every four to eight adults, Cerisflora™ Sour Cherry Concentrate Powder offers functional food and dietary supplement brands a scientifically sophisticated, market-differentiated natural solution for uric acid health and joint comfort.

2. Kelley DS, Adkins Y, Laugero KD. A Review of the Health Benefits of Cherries. Nutrients. 2018;10(3):368.

3. Zhang Y, Neogi T, Chen C, et al. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum. 2012;64(12):4004-4011.

4. Bell PG, Walshe IH, Davison GW, et al. Montmorency cherries reduce the oxidative stress and inflammatory responses to repeated days of high-intensity stochastic cycling. Nutrients. 2014;6(2):829-843.

5. Global Uric Acid & Gout Management Market Analysis & Forecast Report, 2025–2030.

6. World-Way Biotech. In Vivo Hyperuricemia Model Efficacy Study Report (Internal Data).

7. Independent Third-Party Laboratory. HPTLC Botanical Identity Verification Report.